CDK17 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.882990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.132800E-01
Normal-vs-Stage2
2.119400E-01
Normal-vs-Stage3
1.910620E-01
Normal-vs-Stage4
2.760800E-01
Stage1-vs-Stage2
8.393000E-01
Stage1-vs-Stage3
6.431500E-02
Stage1-vs-Stage4
6.622800E-01
Stage2-vs-Stage3
3.59770000000204E-05
Stage2-vs-Stage4
8.212600E-01
Stage3-vs-Stage4
2.666800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.641650E-01
Normal-vs-AfricanAmerican
6.069400E-01
Normal-vs-Asian
2.120600E-01
Caucasian-vs-AfricanAmerican
3.917000E-01
Caucasian-vs-Asian
3.463000E-01
AfricanAmerican-vs-Asian
3.229800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.586230E-01
Normal-vs-Female
2.526600E-01
Male-vs-Female
3.519800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.520000E-01
Normal-vs-Age(41-60Yrs)
4.918400E-01
Normal-vs-Age(61-80Yrs)
1.083220E-01
Normal-vs-Age(81-100Yrs)
8.829800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.781400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.786200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.437000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.841700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.860100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.789200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.059230E-01
Normal-vs-Daily Drinker
2.438200E-02
Normal-vs-Weekly Drinker
2.351200E-01
Normal-vs-Occasional Drinker
3.311000E-01
Normal-vs-Social Drinker
3.497800E-01
Non Drinker-vs-Daily Drinker
3.071200E-01
Non Drinker-vs-Weekly Drinker
7.994600E-01
Non Drinker-vs-Occasional Drinker
2.990600E-01
Non Drinker-vs-Social Drinker
3.025000E-01
Daily Drinker-vs-Weekly Drinker
2.908800E-01
Daily Drinker-vs-Occasional Drinker
5.791500E-02
Daily Drinker-vs-Social Drinker
6.108500E-02
Weekly Drinker-vs-Occasional Drinker
5.597200E-01
Weekly Drinker-vs-Social Drinker
5.529600E-01
Occasional Drinker-vs-Social Drinker
9.690600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.785000E-01
Normal-vs-Grade 2
7.290500E-02
Normal-vs-Grade 3
4.685700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.254000E-01
Grade 1-vs-Grade 3
8.481800E-01
Grade 1-vs-Grade 4
1.785000E-01
Grade 2-vs-Grade 3
8.725400E-01
Grade 2-vs-Grade 4
7.290500E-02
Grade 3-vs-Grade 4
4.685700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.324200E-01
Normal-vs-NonDiabetic
1.259010E-01
Diabetic-vs-NonDiabetic
7.921200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.420200E-02
Normal-vs-NoPancreatitis
1.514990E-01
Pancreatitis-vs-NoPancreatitis
3.286200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.581840E-01
Normal-vs-N1
1.962760E-01
N0-vs-N1
4.409800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.796300E-02
Normal-vs-TP53-NonMutant
2.843200E-01
TP53-Mutant-vs-TP53-NonMutant
1.199600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
